Cargando…

Outcomes of patients with inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes: A population-based study from the SEER program

BACKGROUND: The aim of this study was to evaluate the outcomes of patients with inflammatory breast cancer (IBC), with emphasis on the role of molecular subtypes and radiotherapy. METHODS: A retrospective cohort study to investigate overall survival (OS) and breast cancer-specific mortality (BCSM) i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Juanjuan, Xia, Yue, Wu, Qi, Zhu, Shan, Chen, Chuang, Yang, Wen, Wei, Wen, Sun, Shengrong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564775/ https://www.ncbi.nlm.nih.gov/pubmed/28472761 http://dx.doi.org/10.18632/oncotarget.17217

Ejemplares similares

Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study
por: Wu, Qi, et al.
Publicado: (2017)

Breast carcinoma in situ: An observational study of tumor subtype, treatment and outcomes
por: Wu, Qi, et al.
Publicado: (2016)

Prognostic impact of hormone receptor- and HER2-defined subtypes in inflammatory breast cancer treated with high-dose chemotherapy: a retrospective study
por: Boudin, Laurys, et al.
Publicado: (2016)

Surgical treatment in Paget’s disease with invasive ductal carcinoma: an observational study based on SEER
por: Wu, Qi, et al.
Publicado: (2017)

Adjuvant chemotherapy guidance for pT1–3N0–1 breast cancer patients with HR(+), HER2(−) subtype: a cohort study based on the SEER database
por: Wen, Nan, et al.
Publicado: (2021)

Impact of Breast Cancer Subtype Defined by Immunohistochemistry Hormone Receptor and HER2 Status on the Incidence of Immediate Postmastectomy Reconstruction
por: Wu, Wei, et al.
Publicado: (2016)

Poorer breast cancer survival outcomes in males than females might be attributable to tumor subtype
por: Wu, Qi, et al.
Publicado: (2016)

Different prognosis by subtype in the early mucinous breast cancer: a SEER population-based analysis
por: Lian, Weibin, et al.
Publicado: (2020)

Risk of Second Primary Female Genital Malignancies in Women with Breast Cancer: a SEER Analysis
por: Li, Zhiyu, et al.
Publicado: (2018)

Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study
por: Gong, Yue, et al.
Publicado: (2017)

Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology
por: Ursin, G, et al.
Publicado: (2005)

Postmenopausal Hormone Therapy and Colorectal Cancer Risk by Molecularly Defined Subtypes and Tumor Location
por: Labadie, Julia D, et al.
Publicado: (2020)

Radioactive Iodine Therapy in Patients With Thyroid Carcinoma With Distant Metastases: A SEER-Based Study
por: Li, Chenyuan, et al.
Publicado: (2020)

HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancer
por: Lipton, Allan, et al.
Publicado: (2013)

Immune microenvironment and intrinsic subtyping in hormone receptor-positive/HER2-negative breast cancer
por: Griguolo, Gaia, et al.
Publicado: (2021)

Intrinsic molecular subtypes of HER2+ breast cancer
por: Prat, Aleix, et al.
Publicado: (2017)

Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes
por: Zhang, Fan, et al.
Publicado: (2023)

Immunological profiles of human oligodendrogliomas define two distinct molecular subtypes
por: Wu, Fan, et al.
Publicado: (2022)

The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry
por: Meegdes, Marissa, et al.
Publicado: (2022)

A Molecular and Chemical Perspective in Defining Melatonin Receptor Subtype Selectivity
por: Chan, King Hang, et al.
Publicado: (2013)

The Association of Low-To-Moderate Alcohol Consumption with Breast Cancer Subtypes Defined by Hormone Receptor Status
por: Strumylaite, Loreta, et al.
Publicado: (2015)

Risk prediction of second primary malignancies in patients after rectal cancer: analysis based on SEER Program
por: Sun, Yong-Chao, et al.
Publicado: (2023)

Comparison of pediatric and adult medullary thyroid carcinoma based on SEER program
por: Zhao, Zhuang, et al.
Publicado: (2020)

Molecular subtyping for clinically defined breast cancer subgroups
por: Zhao, Xi, et al.
Publicado: (2015)

DLPFC transcriptome defines two molecular subtypes of schizophrenia
por: Bowen, Elijah F. W., et al.
Publicado: (2019)

Low and Ultra-Low HER2 in Human Breast Cancer: An Effort to Define New Neoplastic Subtypes
por: Franchina, Mariausilia, et al.
Publicado: (2023)

The effect of marital status on glioma patient survival: analysis of 617 cases: A SEER-based study
por: Long, Shengrong, et al.
Publicado: (2018)

Nomograms predicting survival for all four subtypes of breast cancer: a SEER-based population study
por: Chu, Jianli, et al.
Publicado: (2020)

Molecular signatures define alopecia areata subtypes and transcriptional biomarkers
por: Jabbari, Ali, et al.
Publicado: (2016)

Correction: DLPFC transcriptome defines two molecular subtypes of schizophrenia
por: Bowen, Elijah F. W., et al.
Publicado: (2019)

Define the Two Molecular Subtypes of Epithelioid Malignant Pleural Mesothelioma
por: Saddozai, Umair Ali Khan, et al.
Publicado: (2022)

Replication Stress Defines Distinct Molecular Subtypes Across Cancers
por: Takahashi, Nobuyuki, et al.
Publicado: (2022)

A population-based study of Kurdish breast cancer in northern Iraq: Hormone receptor and HER2 status. A comparison with Arabic women and United States SEER data
por: Runnak, Majid A, et al.
Publicado: (2012)

Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: An update
por: Mohanty, Swati Sucharita, et al.
Publicado: (2020)

TP53 mutations among molecular subtypes of HER2-positive tumors
por: Helland, Å, et al.
Publicado: (2005)

Her2 positivity and race predict higher mastectomy rates: a SEER database analysis
por: Schwartz, Theresa L., et al.
Publicado: (2015)

Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systems
por: Eriksson, Pontus, et al.
Publicado: (2015)

Variation in Molecularly Defined Prostate Tumor Subtypes by Self-identified Race
por: Kensler, Kevin H., et al.
Publicado: (2022)

Breast Cancer Subtype as a Predictor of Lymph Node Metastasis according to the SEER Registry
por: Mattes, Malcolm D., et al.
Publicado: (2015)

Racial patterns of patients with primary mediastinal large B-cell lymphoma: SEER analysis
por: Liu, Pan-Pan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hfj365h7j44q189pn54plg4q25